Pharmafile Logo

Peter Impey

- PMLiVE

Britain facing social care ‘time bomb’

Raising awareness of financial realities is key first step, Astellas Debate hears

- PMLiVE

Positive trials bring Pfizer closer to new use for Xeljanz

Rheumatoid arthritis drug performs in two ulcerative colitis trials

Celgene building

Wales backs NHS use of Abraxane despite NICE rejection

Overrules UK decision and will maintain access to Celgene’s pancreatic cancer drug

Why everyone is standing-up to the sitting-down problem

Are the exercise gurus really onto something? Find out how workplace fitness can boost your health and reduce your bum, while helping you become more productive throughout the day.

Say Communications

- PMLiVE

Harnessing the power of ethnography in healthcare

Locating the elusive, yet vital, insights into how people manage and live with their medical conditions

- PMLiVE

The four year itch

Healthcare costs: the most and least important factor

- PMLiVE

Marc Becker joins CRISPR Therapeutics

He becomes chief financial officer

- PMLiVE

Roche integrates diabetes app with Apple Health

Accu-Chek Connect will allow patients to share data with the iPhone system

- PMLiVE

GSK’s chief executive Sir Andrew Witty to retire next year

The announcement follows months of speculation about his position

Sanofi reception

Sanofi bets on DiCE to find oral alternatives to injectable drugs

Makes the US biotech's discovery engine a core part of its R&D portfolio

https://youtu.be/pQATXGemj_0

What we do and who we do it for | Pegasus

We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital...

Inizio

https://youtu.be/Q4JX6garNQk

Understanding decision making in health | Pegasus

To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy...

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links